These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 7513525)

  • 1. Origin, structure and motifs of naturally processed MHC class II ligands.
    Rötzschke O; Falk K
    Curr Opin Immunol; 1994 Feb; 6(1):45-51. PubMed ID: 7513525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure of peptides associated with class I and class II MHC molecules.
    Engelhard VH
    Annu Rev Immunol; 1994; 12():181-207. PubMed ID: 7516668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defining rules for the peptide-MHC class II interaction.
    Sinigaglia F; Hammer J
    Curr Opin Immunol; 1994 Feb; 6(1):52-6. PubMed ID: 7513526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematically benchmarking peptide-MHC binding predictors: From synthetic to naturally processed epitopes.
    Zhao W; Sher X
    PLoS Comput Biol; 2018 Nov; 14(11):e1006457. PubMed ID: 30408041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recognition of core and flanking amino acids of MHC class II-bound peptides by the T cell receptor.
    Sant'Angelo DB; Robinson E; Janeway CA; Denzin LK
    Eur J Immunol; 2002 Sep; 32(9):2510-20. PubMed ID: 12207335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carboxy-terminal residues of major histocompatibility complex class II-associated peptides control the presentation of the bacterial superantigen toxic shock syndrome toxin-1 to T cells.
    Wen R; Broussard DR; Surman S; Hogg TL; Blackman MA; Woodland DL
    Eur J Immunol; 1997 Mar; 27(3):772-81. PubMed ID: 9079821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A pattern search method for putative anchor residues in T cell epitopes.
    Hobohm U; Meyerhans A
    Eur J Immunol; 1993 Jun; 23(6):1271-6. PubMed ID: 7684684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peptide binding motifs for MHC class I and II molecules.
    Biddison WE; Martin R
    Curr Protoc Immunol; 2001 May; Appendix 1():Appendix 1I. PubMed ID: 18432645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MHC class II-associated invariant chain peptide replacement by T cell epitopes: engineered invariant chain as a vehicle for directed and enhanced MHC class II antigen processing and presentation.
    Malcherek G; Wirblich C; Willcox N; Rammensee HG; Trowsdale J; Melms A
    Eur J Immunol; 1998 May; 28(5):1524-33. PubMed ID: 9603457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MHC class II loading of high or low affinity peptides directed by Ii/peptide fusion constructs: implications for T cell activation.
    Gregers TF; Fleckenstein B; Vartdal F; Roepstorff P; Bakke O; Sandlie I
    Int Immunol; 2003 Nov; 15(11):1291-9. PubMed ID: 14565927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Naturally processed HLA class II peptides reveal highly conserved immunogenic flanking region sequence preferences that reflect antigen processing rather than peptide-MHC interactions.
    Godkin AJ; Smith KJ; Willis A; Tejada-Simon MV; Zhang J; Elliott T; Hill AV
    J Immunol; 2001 Jun; 166(11):6720-7. PubMed ID: 11359828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of global amino acid replacements to define the requirements for MHC binding and T cell recognition of moth cytochrome c (93-103).
    Reay PA; Kantor RM; Davis MM
    J Immunol; 1994 Apr; 152(8):3946-57. PubMed ID: 7511662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T cell recognition of major histocompatibility complex class II complexes with invariant chain processing intermediates.
    Morkowski S; Goldrath AW; Eastman S; Ramachandra L; Freed DC; Whiteley P; Rudensky AYu
    J Exp Med; 1995 Nov; 182(5):1403-13. PubMed ID: 7595211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Machine learning reveals a non-canonical mode of peptide binding to MHC class II molecules.
    Andreatta M; Jurtz VI; Kaever T; Sette A; Peters B; Nielsen M
    Immunology; 2017 Oct; 152(2):255-264. PubMed ID: 28542831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Up-regulation of the MHC class II molecules on B cells by peptide ligands.
    Agrawal B; Fraga E; Kane K; Singh B
    J Immunol; 1994 Feb; 152(3):965-75. PubMed ID: 8301149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of structural requirements for interaction of the same peptide with I-Ek and I-Ed molecules in the activation of MHC class II-restricted T cells.
    Leighton J; Sette A; Sidney J; Appella E; Ehrhardt C; Fuchs S; Adorini L
    J Immunol; 1991 Jul; 147(1):198-204. PubMed ID: 1711074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A continuous central motif of invariant chain peptides, CLIP, is essential for binding to various I-A MHC class II molecules.
    Weenink SM; Milburn PJ; Gautam AM
    Int Immunol; 1997 Feb; 9(2):317-25. PubMed ID: 9040013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterizing immunodominant and protective influenza hemagglutinin epitopes by functional activity and relative binding to major histocompatibility complex class II sites.
    Rajnavölgyi E; Horváth A; Gogolák P; Tóth GK; Fazekas G; Fridkin M; Pecht I
    Eur J Immunol; 1997 Dec; 27(12):3105-14. PubMed ID: 9464794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Consensus motifs and peptide ligands of MHC class I molecules.
    Falk K; Rötzschke O
    Semin Immunol; 1993 Apr; 5(2):81-94. PubMed ID: 7684938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Supermotifs enable natural invariant chain-derived peptides to interact with many major histocompatibility complex-class II molecules.
    Malcherek G; Gnau V; Jung G; Rammensee HG; Melms A
    J Exp Med; 1995 Feb; 181(2):527-36. PubMed ID: 7836909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.